Finding a clinical-stage biotechnology company in the heart of Kansas City might seem incongruous. “People tend to think of us as ‘flyover’ territory,’” says Brent Kreider, president of BioMed Valley Discoveries. However, since 2007, this member of the Stowers group has been doing research that may lead to treating the world’s most deadly diseases. Kreider… Continue reading A local biotech company has a $2 billion endowment and a mission to “de-risk” research
A local biotech company has a $2 billion endowment and a mission to “de-risk” research